Compound atlas
Metabolic
Tirzepatide
Also known as · Mounjaro · Zepbound
Half-life
120h
approx. mean t½
Dose range
2.5–15 mg / week
typical, not prescriptive
Category
Metabolic
primary use-case
— Overview
Dual GIP/GLP-1 receptor agonist. Superior weight loss and glycemic control vs semaglutide in head-to-head trials.
— Mechanism of action
Activates both GIP and GLP-1 receptors. Enhanced insulin sensitivity and appetite suppression compared to GLP-1 monoagonists.
— Typical protocol
SubQ weekly. Titrate: 2.5 → 5 → 7.5 → 10 → 12.5 → 15 mg.
— Storage
Refrigerated. Stable at room temp up to 21 days once in use.
Disclaimer
This page summarizes publicly available information. None of it constitutes medical advice, prescription, or recommendation to acquire, possess, or use any compound. Many peptides described are research chemicals not approved for human use in the EU. Consult a licensed physician.